| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |